1. Home
  2. WVE vs MCB Comparison

WVE vs MCB Comparison

Compare WVE & MCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Wave Life Sciences Ltd.

WVE

Wave Life Sciences Ltd.

N/A

Current Price

$5.25

Market Cap

1.0B

Sector

Health Care

ML Signal

N/A

Logo Metropolitan Bank Holding Corp.

MCB

Metropolitan Bank Holding Corp.

N/A

Current Price

$90.90

Market Cap

1.2B

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
WVE
MCB
Founded
2012
1999
Country
Singapore
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
1.2B
IPO Year
2015
2017

Fundamental Metrics

Financial Performance
Metric
WVE
MCB
Price
$5.25
$90.90
Analyst Decision
Strong Buy
Buy
Analyst Count
16
3
Target Price
$29.81
$98.67
AVG Volume (30 Days)
3.2M
102.2K
Earning Date
04-28-2026
04-21-2026
Dividend Yield
N/A
1.13%
EPS Growth
N/A
11.64
EPS
N/A
4.40
Revenue
$3,704,000.00
$11,053,000.00
Revenue This Year
N/A
$37.22
Revenue Next Year
$85.67
$14.75
P/E Ratio
N/A
$20.56
Revenue Growth
149.43
N/A
52 Week Low
$5.01
$64.66
52 Week High
$21.73
$102.04

Technical Indicators

Market Signals
Indicator
WVE
MCB
Relative Strength Index (RSI) 44.72 39.45
Support Level $5.02 $86.40
Resistance Level $6.39 $92.99
Average True Range (ATR) 0.33 1.64
MACD -0.01 -0.20
Stochastic Oscillator 21.43 6.96

Price Performance

Historical Comparison
WVE
MCB

About WVE Wave Life Sciences Ltd.

WAVE Life Sciences Inc is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.

About MCB Metropolitan Bank Holding Corp.

Metropolitan Bank Holding Corp is a bank holding company. It provides a broad range of business, commercial, and retail banking products and services to small businesses, middle-market enterprises, public entities, and individuals in the New York metropolitan area. The services provided by the company include deposits, trade finance, cash management solutions, savings, electronic banking, cards, and others. The company also provides various lending products such as acquisition loans, construction loans, and lines of credit, for retail, office, hospitality, multifamily, mixed-use, warehouse and distribution, and specialty-use properties. The bank derives its revenue in the form of interest income on loans.

Share on Social Networks: